-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

332.P1.33 332. Anticoagulation and Antithrombotic Therapy: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, anticoagulant drugs, Biological, Coronaviruses, SARS-CoV-2/COVID-19, survivorship, viral, Bleeding and Clotting, Diseases, Hemostasis, Non-Biological, Combinations, Elderly, Therapies, Adverse Events, Genetic Disorders, Pediatric, Thrombosis, Young Adult, Infectious Diseases, Protein Disorders, Study Population, Thromboembolism, Clinically relevant, Quality Improvement , Thrombotic Disorders, VTE
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Agnes Y. Lee, MD, MSc1, Pieter W. Kamphuisen, MD, PhD2*, Rupert Bauersachs, MD, PhD3,4*, Karen Turpin, BScN, MSc5*, Jes Birger Hansen6* and Alok A Khorana, MD7

1Department of Hematology, University of British Columbia, Vancouver, BC, Canada
2University Medical Center Groningen, Groningen, NLD
3Department Vascular Medicine, Darmstadt Hospital, Darmstadt, DEU
4Center of Thrombosis and Haemostasis, University of Mainz, Mainz, Germany
5Medical Affairs, Leo Pharma Canada, Thornhill, ON, Canada
6LEO Pharma A/S, Ballerup, France
7Taussig Cancer Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH

Jasmeet Kaur, MD, MBBS1, Anupam A Sule, MD, PhD, FACP1*, Tracy Koehler2*, Geetha Krishnamoorthy, MD, FACP1* and Jennifer DeLongpre, MD3*

1Department of Internal Medicine, Saint Joseph Mercy Oakland Hospital, Pontiac, MI
2Saint Joseph Mercy Oakland Hospital, Pontiac
3Department of Internal Medicine, Mercy Health Muskegon, Muskegon, MI

Leonardo R. Brandao, MD1, Igor Tartakovsky, MD2*, Manuela Albisetti, MD3*, Lisa Bomgaars, MD4*, Elizabeth Chalmers, MD5*, Lesley Mitchell, MD6*, Matteo Luciani, MD7*, Paola Saracco, MD8*, Judy Felgenhauer, MD9*, Olga Lvova, MD10,11*, Monika Simetzberger, DI12*, Zhichao Sun, PhD13*, Ingrid Gergei, MD2*, Martina Brueckmann, MD2,14* and Jacqueline Halton, MD15*

1Paediatric Haemotology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
2Therapeutic Area Cardiovascular Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Germany
3Hematology Department, University Children’s Hospital, Zürich, Switzerland
4Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX
5Royal Hospital for Children, Glasgow, United Kingdom
6University of Alberta, Edmonton, Canada
7Pediatric Hematology/Oncology Department, Pediatric Hospital Bambino Gesù, Rome, Italy
8University Hospital, City of Health and Science of Turin, and Pediatric Hematology, Queen Margaret’s Children's Hospital, Turin, Italy
9Pediatric Hematology Oncology, Providence Sacred Heart Medical Center and Children's Hospital, Spokane, WA
10Ural Federal University, Yekaterinburg, Russian Federation
11Children’s City Hospital #9, Yekaterinburg, Russian Federation
12Department of Clinical Development, Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria
13Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
14Faculty of Medicine Mannheim of the University of Heidelberg, Mannheim, Germany
15University of Ottawa, Children’s Hospital of Eastern Ontario, Ottawa, Canada

Lisa Baumann Kreuziger, MD1,2, Mingen Feng, MS2*, Abigail Bartosic, CCRP3*, Pippa Simpson, PhD2* and Tzu-Fei Wang, MD, MPH4

1Versiti, Blood Research Institute, Milwaukee, WI
2Medical College of Wisconsin, Milwaukee, WI
3The Ohio State University, Columbus, OH
4Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Daniel Röshammar, PhD1*, Fenglei Huang, PhD2*, Manuela Albisetti, MD3*, Lisa Bomgaars, MD4*, Elizabeth Chalmers, MD5*, Matteo Luciani, MD6*, Jacqueline Halton, MD7*, Lesley Mitchell, MD8*, David Joseph, PhD2*, Igor Tartakovsky, MD9*, Savion Gropper, MD10*, Martina Brueckmann, MD9,11* and Leonardo R. Brandao, MD12

1Pharmetheus AB, Uppsala, Sweden
2Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
3Hematology Department, University Children’s Hospital, Zürich, Switzerland
4Department of Pediatrics, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX
5Royal Hospital for Children, Glasgow, United Kingdom
6Pediatric Hematology/Oncology Department, Pediatric Hospital Bambino Gesù, Rome, Italy
7University of Ottawa, Children’s Hospital of Eastern Ontario, Ottawa, Canada
8University of Alberta, Edmonton, Canada
9Therapeutic Area Cardiovascular Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Germany
10Therapeutic Area Inflammation Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Germany
11Faculty of Medicine Mannheim of the University of Heidelberg, Mannheim, Germany
12Paediatric Haemotology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada

Juan Cardenas, PhD1*, Jayaprakash Kotha, PhD, MBBS1*, Genmin Lu2*, Pamela B. Conley, PhD3*, Matthieu Bourdin4*, Tristan Herve5* and Lisa K. Jennings, PhD1

1CirQuest Labs, LLC as MLM Medical Labs, LLC, Memphis, TN
2Portola Pharmaceuticals, Inc., a wholly owned subsidiary of Alexion Pharmaceuticals, Inc., Burlingame, CA
3Portola Pharmaceuticals, Inc., a wholly owned subsidiary of Alexion Pharmaceuticals, Inc., South San Francisco, CA
4Diagnostica Stago, Gennevilliers, France
5Diagnostica Stago, Asnieres sur Seine Cedex, France

Lantarima Bhoopat, MD1*, Anastasia Martynova, MD2, April Choi, MD3*, Pattharawin Pattharanitima, MD4*, Semi Han, MD5*, Senxi Du6*, Ibrahim Syed7*, Catherine Chan, PharmD8*, Caitlin O'Neill, MD9, Esther Oh, PharmD10* and Casey L. O'Connell, MD11

1Hematology, Department of Internal Medicine, Thammasat University, Patumthani, Thailand
2University of Southern California, Jane Anne Nohl Division of Hematology, Los Angeles, CA
3Depatment of Internal Medicine, University of Southern California, Los Angeles, CA
4Nephrology, Department of Internal Medicine, Thammasat University, Patumthani, Thailand
5Department of Internal Medicine, University of Southern California, Los Angeles, CA
6University of Southern California, Keck School of Medicine, Los Angeles, CA
7Jane Anne Nohl Division of Hematology, Keck School of Medicine of the University of Southern California, Los Angeles, CA
8LAC+USC Medical Center, Los Angeles, CA
9University of Southern California, Jane Anne Nohl Division of Hematology, Keck School of Medicine, Los Angeles, CA
10LAC+USC Medical Center, Los Angles, CA
11Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

Fakiha Siddiqui1*, Debra Hoppensteadt, PhD1*, Jeanine Walenga, PhD2, Walter Jeske, PhD2*, Alfonso J Tafur, MD, MS3*, Eduardo Ramacciotti, PhD, MD1* and Jawed Fareed, PhD1

1Pathology, Loyola University Medical Center, Maywood, IL
2Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, IL
3Cardiology - Vascular Medicine., NorthShore University HealthSystem, Evanston, IL

Rich Kodama, MD1*, Amardeep Kalsi, MD1*, Angelica Singh, MD2*, Nivetha Vishnuvardhan, MD2, Neil Nimkar, MD1, Sonal Paul, MD2, Soeb Usta, MD1*, Farah Ashraf, MD1*, Anita Mazloom, MD1, Abeer Ashfaq, MD1*, Nisha Patel, MD1*, Chathula Kumarasinghe, MD1*, Uqba Khan, MD1*, Peter Gregos, MD1, Jeremy Weingarten, MD1* and Eshan Patel, MD2

1New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY
2NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY

Camille Simard, MD1*, Maral Koolian, MD, MSc, FRCPC2*, Diana Escobar, MD3*, Mark Blostein, MD FRCPC4*, Jed Lipes, MD, FRCPC5*, Adelina Teona Avram, MD1*, Ryan Kerzner, B Pharm, MSc6*, Helen Mantzanis, B Pharm, MSc6*, Mateo Porres Aguilar, MD1* and Vicky Tagalakis, MD, FRCPC7

1McGill University, Montreal, QC, Canada
2General Internal Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada
3McGill University, Monteal, QC, Canada
4Division of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada
5Critical Care Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada
6Department of Pharmacy, Jewish General Hospital, Montreal, QC, Canada
7Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada

*signifies non-member of ASH